Peptide Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 10
SKU : PH1168
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Peptide Therapeutics Market?
Peptide Therapeutics Market is expected to grow at a CAGR of 7.8% during the forecast period 2024-2031.
Who are the key players in Peptide Therapeutics Market?
Key players are Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, and Novo Nordisk AS.
Related Reports
pharmaceuticalsImpetigo Therapeutic Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2022 December 28
Starting from
$4350
pharmaceuticalsProtein Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 29
Starting from
$4350
pharmaceuticalsLeukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 05
Starting from
$4350
pharmaceuticalsDiabetes Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350
pharmaceuticalsAlopecia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350
pharmaceuticalsNuclear Medicine Radioisotopes Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
Starting from
$4350